Clinical trial
Effects of Fluticasone On Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
NCT00175565 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Fluticasone On Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
- Lead sponsor
- University of British Columbia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- July 31, 2003
- Enrollment
- 50
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic bronchitis, chronic obstructive pulmonary disease, emphysema